---
title: "HSN Code for Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine | HSN 30049055 GST Rate"
description: "Find HSN and GST Rates for 30049055 related to Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine with BUSY Accounting - The reliable source for HSN and GST details in India."
canonical: "https://busy.in/hsn/hsn-30049055/"
---

# HSN Code 30049055: Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine

- [Section 06: Guide to HSN Section 06](https://busy.in/hsn/section-06/)
- [Chapter 30: Pharmaceutical Products](https://busy.in/hsn/chapter-30/)
- [Sub-chapter 3004: Medicaments for therapeutic uses](https://busy.in/hsn/sub-chapter-3004/)

## GST rates

| Description | CGST | SGST | IGST | CESS |
| --- | --- | --- | --- | --- |
| Other : Antitubercular drugs; antileprotic drugs; antimalarial drugs : Dapsone (DDS), acedapsone (DADDS), solopsone and clofazimine | 6% | 6% | 12% | 0% |

## Frequently asked questions

### What products are classified under HSN 30049055 ?

It includes Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine

### Does packaging or labelling change the GST for Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine?

For food/agri items, GST can be 5% when not fresh/chilled and sold as pre‑packaged & labelled; otherwise often Nil. For non‑food items, rates depend on the specific sub‑heading.

### Can we claim ITC on inputs used to trade Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine?

If your outward supply is taxable, eligible ITC is available subject to general restrictions. For exempt/Nil supplies, reverse credit per Rule 42.

### Any common misclassification issue with Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine?

Use the exact HSN and describe the form/grade. For multi‑line invoices, apply the rate per line to avoid wrong tax collection.

### How much GST applies to Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine?

Under HSN 30049055, Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine attracts Varies when sold in taxable form. Describe the exact form on the invoice.

### How should mixed supplies be billed when Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine is sold with other items?

Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine; Nil for exempt items if applicable).

## India's trade performance: HSN Code 30049055 (FY 2024-25)

Source: TradeStat EIDB, Ministry of Commerce & Industry. Values in ₹ Crore (FY 2018-19 to FY 2024-25).

- Exports: ₹70 Cr (−42.93% YoY) — 0.0019% of India's total exports
- Imports: Nil (−100.00% YoY) — 0.0000% of India's total imports
- Trade balance: ₹70 Cr (Surplus); surplus rank #1887 of 12657 HSN codes
- Share of Sub-Chapter 3004: 0.04% of its exports; import side 0.00%
- Rank within Sub-Chapter 3004: #88 of 149 by export value

### Key metrics

- Export CAGR: 42.86% (FY 2018-19 to FY 2024-25, 7 fiscal years)
- National export rank: #3151 of 12657 HSN codes by export value (FY 2024-25)
- Peak growth year: +402.60% in FY 2020-21
- Contribution to Sub-Ch. 3004: 0.04% of its exports (FY 2024-25)

## India export-import trade statistics: HSN Code 30049055

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

| FY | Exports (₹ Cr) | Exp share | Exp YoY | Exp % of Sub-Ch. 3004 | Imports (₹ Cr) | Imp share | Imp YoY | Imp % of Sub-Ch. 3004 | Trade balance | Exp rank |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY 2018-19 | 8.23 | 0.0004% | — | 0.01% | 39.40 | 0.0011% | — | 0.53% | −31.17 | #5231 |
| FY 2019-20 | 5.78 | 0.0003% | −29.77% | 0.01% | 38.38 | 0.0011% | −2.59% | 0.50% | −32.60 | #5677 |
| FY 2020-21 | 29.05 | 0.0014% | +402.60% | 0.02% | 44.91 | 0.0015% | +17.01% | 0.56% | −15.86 | #3710 |
| FY 2021-22 | 105.87 | 0.0034% | +264.44% | 0.08% | 59.40 | 0.0013% | +32.26% | 0.45% | +46.47 | #2336 |
| FY 2022-23 | 101.65 | 0.0028% | −3.99% | 0.07% | 23.47 | 0.0004% | −60.49% | 0.25% | +78.18 | #2505 |
| FY 2023-24 | 122.61 | 0.0034% | +20.62% | 0.08% | < ₹1 Crore | 0.0000% | −99.96% | 0.00% | +122.60 | #2330 |
| FY 2024-25 | 69.97 | 0.0019% | −42.93% | 0.04% | Nil | 0.0000% | −100.00% | 0.00% | +69.97 | #3151 |

- CAGR (7-year): exports 42.86%/yr, imports —/yr (consistently Surplus)

## Key trade insights: HSN Code 30049055 export-import analysis

### Consistent export growth: 42.86% CAGR over 7 years

India's exports under HSN Code 30049055 have grown at a compound annual rate of 42.86% over 7 fiscal years, rising from ₹8.23 Crore in FY 2018-19 to ₹69.97 Crore in FY 2024-25.

### HSN Code 30049055 ranked #3151 among all 12657 HSN codes by export value

In FY 2024-25, HSN Code 30049055 ranks #3151 out of 12657 HSN codes by total export value. Within Sub-Chapter 3004, it ranks #88 of 149. By trade surplus, it ranks #1887 of 12657.

### FY 2020-21 was the strongest growth year for HSN Code 30049055 exports

The strongest single-year export movement for HSN Code 30049055 was recorded in FY 2020-21, when exports surged by 402.60% over the prior year.

### India maintains a trade surplus of ₹69.97 Crore in HSN Code 30049055 goods

In FY 2024-25, India's exports of ₹69.97 Cr exceeded imports of ₹0.00 Cr, resulting in a trade surplus of ₹69.97 Crore — ranking #1887 of 12657 by surplus magnitude.

### HSN Code 30049055 contributes 0.04% of Sub-Chapter 3004 exports — ranked #88

Among the 149 HSN codes under Sub-Chapter 3004, HSN Code 30049055 ranks #88 by export value — accounting for 0.04% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 0.00% share.

## Related HSN Codes in Sub-Chapter 3004

Ranked by export value (FY 2024-25).

| Rank | HSN Code | Exports (FY 2024-25) |
| --- | --- | --- |
| #1 | [HSN Code 30049099: Other therapeutic or prophylactic use products](https://busy.in/hsn/hsn-30049099/) | ₹82,761 Cr |
| #2 | [HSN Code 30049049: Other \| Anticancer Drugs](https://busy.in/hsn/hsn-30049049/) | ₹19,872 Cr |
| #3 | [HSN Code 30049079: Other \| Antihypertensive Drugs](https://busy.in/hsn/hsn-30049079/) | ₹9,153 Cr |
| #4 | [HSN Code 30049069: Nonsteroidal Analgesics & Antipyretics: Other Medicaments](https://busy.in/hsn/hsn-30049069/) | ₹7,577 Cr |
| #5 | [HSN Code 30049039: Other Antihistaminics/Antacids/Antiulcer/Antiemetics](https://busy.in/hsn/hsn-30049039/) | ₹5,465 Cr |
| #6 | [HSN Code 30041090: Other Penicillins or Streptomycins](https://busy.in/hsn/hsn-30041090/) | ₹3,685 Cr |
| #7 | [HSN Code 30042019: Other Cephalosporin Antibiotics](https://busy.in/hsn/hsn-30042019/) | ₹3,036 Cr |
| #8 | [HSN Code 30049081: Antiepileptic & Sulfa Drugs](https://busy.in/hsn/hsn-30049081/) | ₹2,870 Cr |
| #9 | [HSN Code 30049082: Other Antiepileptic Drugs](https://busy.in/hsn/hsn-30049082/) | ₹2,860 Cr |
| #10 | [HSN Code 30049029: Other Anthelmintic/Antiamoebic/Antifungal Drugs](https://busy.in/hsn/hsn-30049029/) | ₹2,697 Cr |
| #88 | HSN Code 30049055: Dapsone (DDS), Acedapsone (DADDS), Solopsone, Clofazimine (this hsn code) | ₹70 Cr |